The United States is the world’s largest pharmaceutical market. China’s biomedicine has gradually overtaken the United States in the fields of approval and listing, drug R & D personnel training, enterprise output value and pharmaceutical financing
The United States is the world’s largest pharmaceutical market, and China Meheco Group Co.Ltd(600056) market share in the world is increasing year by year. Compared with the biomedical market in China and the United States, the number of approved innovative drugs in China and the United States is at an all-time high in pharmaceutical approval. The number of approved innovative drugs in China has gradually caught up with that in the United States, and tumor drugs are still the majority of approved innovative drugs in the two countries; In terms of drug R & D, the United States is the country with the largest investment in pharmaceutical R & D in the world. As the world’s second-largest pharmaceutical market, the growth rate of drug R & D investment in China far exceeds the global level, and the R & D of pharmaceutical enterprises is in the late stage of catching up; In terms of medical talents, China has a rich reserve of high-quality biomedical professionals, and the labor cost and per capita efficiency are higher than those overseas; In terms of enterprise output value, Chinese pharmaceutical enterprises are in the stage of transformation and catch-up, and biomedical enterprises dominated by innovative drugs are in the growth stage; In terms of pharmaceutical financing, the United States is the hottest region for investment and financing in the global medical and health industry. The amount of medical and health financing and financing events between China and the United States have increased year by year in recent three years
Israel is the second largest supplier of medical devices in the world and the country with the most extensive use of information technology in the field of medical device manufacturing in the world
Israel is the second largest supplier of medical devices in the world. There are nearly 200 life science industry companies in the country. Its life science industry can be divided into four fields: medical devices, biotechnology, health care it and drug research. The industry focuses on the field of medical devices
Japan’s elderly care industry has become one of the pillar industries. Japan’s elderly care industry is mature, and professional elderly care services are worth learning from China’s elderly care industry
The global mainstream pension model is mainly based on the diversified participation model of the United States in developed countries, the national welfare model of the United Kingdom and the nursing insurance model of Japan. At present, China’s pension model has formed a diversified pension service system covering urban and rural areas based on home, supported by community and supported by institutions
Compared with Japan’s mature pension industry, although China’s pension industry has expanded rapidly with the change of population structure, the number of elderly groups with high income, high culture and accepting the commercial pension model is far less than the market expectation
